Yulong Bai
ORCID: 0000-0002-9365-3742Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 9 papers. Top paper: “Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial”.
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Robert M. Morrison, Amiran Dzutsev, Arivarasan Karunamurthy, Joë-Marc Chauvin, F. Amatore +48 more
Joë-Marc Chauvin, Robert Morrison, Yulong Bai, Jie Sun, Hong Wang +22 more
Zhenjiang Fan, Yulong Bai, Qidong Ren, Youssef Rbaibi, Kimberly R. Long +6 more
Yulong Bai, Yarong Tian, Sanna Abrahamsson, Anthony R. Green, John Allphin Moore +6 more
Yulong Bai, Zhenjiang Fan, Brenda Diergaarde, George C. Tseng, Hyun Jung Park +1 more
Yidi Qin, Zhenjiang Fan, Robert M. Morrison, Kyong Nyon Nam, Hassane M. Zarour +5 more
Arivarasan Karunamurthy, Joë-Marc Chauvin, Robert M. Morrison, Yulong Bai, Jie Sun +40 more
Yarong Tian, Yulong Bai, Sanna Abrahamsson, Alan Bäckerholm, Alex S. Reznik +8 more
Soyeon Kim, Yulong Bai, Brenda Diergaarde, Hyun Jung Park, Zhenjiang Fan